About this trial
The overall objective of this project is to identify the key salt-sensing regions of the brain and determine the underlying mechanism of sodium sensing. The investigators will assess how the brain responds to an acute increase of salt in the blood using MRI. This will be done during a 30-minute infusion of a saline solution containing 3% salt. One trial will be conducted with a salt sensing channel blocker and one trial without the salt sensing channel blocker. This will help to assess the role of a specific salt sensing channel in the brain. Salt sensitivity of BP will be assessed using 7-day dietary feeding where participants will be given food to consume for 7-days. Comparisons will be made between salt resistant (no change in blood pressure going from low to high salt diets) and salt sensitive adults (a change in blood pressure going from low to high salt diets). The investigators think the changes in MRI will be greater in salt sensitive compared to salt resistant subjects.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age: > 40 years or < 60 years
Blood pressure: > 100/60 mmHg or < 140/90 mmHg
BMI: > 18.5 kg/m2 or < 35 kg/m2
Serum potassium: > 3.5 mmol/L or < 5.5 mmol/L
Disqualifiers
Age: < 40 years or > 60 years
Blood pressure: < 100/60 mmHg or > 140/90 mmHg
BMI: < 18.5 kg/m2 or > 30 kg/m2
Serum potassium: < 3.5 mmol/L or > 5.5 mmol/L
Trial design
Crossover
Treatments tested in this trial
Furosemide (Diuretic)
DrugThe diuretic furosemide will be given during a 3% hypertonic saline infusion to examine blockade of the NKCC2.
Hypertonic Saline Infusion
Other intervention3% Hypertonic saline infusion to acutely increase sodium and osmolality
Treatment groups
Trial outcomes
Primary outcomes
Bold fMRI
Intensity of sodium sensing regions of the brain
Secondary outcomes
Blood Pressure
Systolic and Diastolic Blood pressure responses to hypertonic saline
Other outcomes
Sympathetic Nerve Activity
sympathetic bursts per minute
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Delaware
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator